We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+25.89%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$374M
AUM Growth
+$16.3M
(+4.5%)
Cap. Flow
-$27.4M
Cap. Flow
% of AUM
-7.31%
Top 10 Holdings %
Top 10 Hldgs %
27.08%
Holding
761
New
59
Increased
126
Reduced
253
Closed
72
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI China ETF
MCHI
|
+$10.6M |
| 2 |
iShares MSCI South Africa ETF
EZA
|
+$7.66M |
| 3 |
iShares MSCI Malaysia ETF
EWM
|
+$6.49M |
| 4 |
UBS Group
UBS
|
+$5.93M |
| 5 |
Linde
LIN
|
+$5.76M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RSX
VanEck Russia ETF
RSX
|
+$10.6M |
| 2 |
iShares MSCI Turkey ETF
TUR
|
+$10.5M |
| 3 |
VanEck Gold Miners ETF
GDX
|
+$9.79M |
| 4 |
iShares MSCI Poland ETF
EPOL
|
+$8.27M |
| 5 |
Merck
MRK
|
+$3.11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.4% |
| 2 | Technology | 12.96% |
| 3 | Financials | 11.29% |
| 4 | Healthcare | 10.46% |
| 5 | Consumer Discretionary | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Qorvo
QRVO
$10.4B
| $171K | 0.05% |
+1,545
| New | +$153K |
|
|
MYOK
227
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $170K | 0.05% |
1,763
-27
| -2% | -$2.25K |
|
228
3M
MMM
$84.9B
| $162K | 0.04% |
+1,241
| New | +$156K |
|
229
CALL
Alcon
ALC
$32.8B
| $160K | 0.04% |
1,256
+1,200
| +2,143% | +$67.9K |
|
|
X
230
DELISTED
US Steel
X
| $158K | 0.04% |
21,891
-29,709
| -58% | -$232K |
|
|
TWTR
231
DELISTED
Twitter, Inc.
TWTR
| $158K | 0.04% |
5,292
-2,382
| -31% | -$71.8K |
|
232
Ralph Lauren
RL
$20B
| $153K | 0.04% |
2,112
-928
| -31% | -$68.2K |
|
233
Petrobras
PBR
$140B
| $153K | 0.04% |
18,470
-225,806
| -92% | -$1.64M |
|
234
Itaú Unibanco
ITUB
$91B
| $152K | 0.04% |
+44,458
| New | +$144K |
|
235
Moderna
MRNA
$57.4B
| $151K | 0.04% |
+2,350
| New | +$129K |
|
236
Kodiak Sciences
KOD
$2.07B
| $151K | 0.04% |
2,788
-628
| -18% | -$35.4K |
|
|
RCS
237
PIMCO Strategic Income Fund
RCS
$232M
| $147K | 0.04% |
23,001
-55,000
| -71% | -$361K |
|
238
iShares Floating Rate Bond ETF
FLOT
$10.8B
| $144K | 0.04% |
2,837
+294
| +12% | +$14.7K |
|
239
PUT
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$29.1B
| $143K | 0.04% |
1,200
+300
| +33% | +$39K |
|
|
IGMS
240
DELISTED
IGM Biosciences
IGMS
| $142K | 0.04% |
1,952
+322
| +20% | +$19.6K |
|
|
ONC
241
BeOne Medicines Ltd
ONC
$39.2B
| $141K | 0.04% |
750
| – | – |
|
|
CDTX
242
DELISTED
Cidara Therapeutics
CDTX
| $141K | 0.04% |
1,911
| – | – |
|
|
GTHX
243
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $140K | 0.04% |
5,767
+29
| +0.5% | +$480 |
|
244
Home Depot
HD
$305B
| $139K | 0.04% |
555
-483
| -47% | -$111K |
|
245
STAG Industrial
STAG
$7.16B
| $139K | 0.04% |
4,740
+4,719
| +22,471% | +$124K |
|
246
Estee Lauder
EL
$34.8B
| $138K | 0.04% |
733
-736
| -50% | -$132K |
|
|
ALXN
247
DELISTED
Alexion Pharmaceuticals
ALXN
| $138K | 0.04% |
1,232
-4,928
| -80% | -$523K |
|
248
Alexandria Real Estate Equities
ARE
$9.11B
| $136K | 0.04% |
836
-395
| -32% | -$60.4K |
|
249
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.25B
| $134K | 0.04% |
1,721
+179
| +12% | +$13.3K |
|
|
SGEN
250
DELISTED
Seagen Inc. Common Stock
SGEN
| $133K | 0.04% |
785
-215
| -22% | -$32.1K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q2 2020 Portfolio in Review
As of Q2 2020, Exane Derivatives held 761 positions worth $374M, up 4.5% from $358M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Exane Derivatives withdrew a net $27.4M in Q2 2020, closing 72 positions and reducing 253 holdings. Its most notable exit was iShares MSCI Turkey ETF, an estimated $10.5M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Exane Derivatives opened a new position in iShares MSCI South Africa ETF worth $8.2M.
- Exane Derivatives's largest Q2 2020 buy was iShares MSCI South Africa ETF: 232,582 shares worth $8.2M.
- Exane Derivatives added most to iShares MSCI China ETF in Q2 2020, an estimated $10.6M increase.
- Exane Derivatives's biggest Q2 2020 reduction was VanEck Russia ETF, cutting an estimated $10.6M.
- Exane Derivatives fully exited iShares MSCI Turkey ETF in Q2 2020, selling an estimated $10.5M.
- Exane Derivatives's ten largest holdings make up 27% of its $374M portfolio in Q2 2020.
- Exane Derivatives opened 59 new positions and closed 72 in Q2 2020.
- Exane Derivatives's portfolio value rose 4.5% quarter-over-quarter to $374M.
Based on Exane Derivatives's 13F filing for Q2 2020, filed 10 Jul 2020.